{"id":73,"date":"2024-03-11T12:53:18","date_gmt":"2024-03-11T12:53:18","guid":{"rendered":"https:\/\/admit:8890\/?p=73"},"modified":"2024-11-07T13:06:15","modified_gmt":"2024-11-07T13:06:15","slug":"admit-therapeutics-participo-la-semana-pasada-en-el-addf-investigators-day-y-en-el-congreso-ad-pd-2024-celebrados-en-lisboa","status":"publish","type":"post","link":"https:\/\/admit-therapeutics.com\/es\/admit-therapeutics-participo-la-semana-pasada-en-el-addf-investigators-day-y-en-el-congreso-ad-pd-2024-celebrados-en-lisboa\/","title":{"rendered":"ADmit Therapeutics particip\u00f3 la semana pasada en el ADDF Investigators Day y en el congreso AD\/PD 2024 celebrados en Lisboa"},"content":{"rendered":"\n<p>Nuestra CEO particip\u00f3 en el \u00a0Alzheimer&#8217;s Drug Discovery Foundation Investigators Day para explicar la tecnolog\u00eda de ADmit basada en biomarcadores noveles en sangre para pronosticar la enfermedad de Alzheimer. Adem\u00e1s, se presentaron dos p\u00f3sters durante el congreso AD\/PD 2024 en Lisboa (Poster Shift1 0299: Analytical validation of blood mitochondrial methylcytosines for the prognosis of AD dementia progression at MCI stage, y Poster Shift1 0487: Diagnosis of Dementia with Lewy Bodies based on a NGS analysis of blood mitochondrial methylcytosines: a machine learning approach) por Marta Blanch, nuestra directora de desarrollo de producto.<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nuestra CEO particip\u00f3 en el \u00a0Alzheimer&#8217;s Drug Discovery Foundation Investigators Day para explicar la tecnolog\u00eda de ADmit basada en biomarcadores noveles en sangre para pronosticar la enfermedad de Alzheimer. Adem\u00e1s, se presentaron dos p\u00f3sters durante el congreso AD\/PD 2024 en Lisboa (Poster Shift1 0299: Analytical validation of blood mitochondrial methylcytosines for the prognosis of AD [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-73","post","type-post","status-publish","format-standard","hentry","category-sin-categorizar"],"acf":[],"_links":{"self":[{"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/posts\/73","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/comments?post=73"}],"version-history":[{"count":1,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/posts\/73\/revisions"}],"predecessor-version":[{"id":74,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/posts\/73\/revisions\/74"}],"wp:attachment":[{"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/media?parent=73"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/categories?post=73"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/es\/wp-json\/wp\/v2\/tags?post=73"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}